Skip to Content

Santen Pharmaceutical Co Ltd SNPHF Stock Quote

| Rating as of


Last close prices updated as of May 23, 2023, 10:49 AM EST | USD
  • Last Close 9.59
  • Sector Healthcare
  • Industry Drug Manufacturers - General
  • Investment Style Mid Blend
  • Day Range 9.59  –  9.59
  • Year Range 6.25  –  9.59
  • Market Cap 3.6033 Bil
  • Volume / Avg 109.0 /  3,857.6
  • Price / Sales 1.95
  • Price / Book 1.67
  • Forward Div Yield 2.49%
  • Trailing Div Yield 333.54%

Morningstar‘s Stock Analysis SNPHF

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics SNPHF

Company Profile SNPHF

Business Description

Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company reports two primary operating segments: prescription ophthalmic pharmaceuticals and other. The pharmaceuticals segment includes over-the-counter pharmaceuticals, while the other segment includes medical devices. The vast majority of Santen's revenue is derived from its prescription ophthalmic pharmaceuticals segment, which manufactures and distributes prescription and OTC pharmaceuticals. Most of Santen's sales are generated in Japan, followed by other Asian countries.

Grand Front Osaka Tower A, 4-20 Ofuka-cho, Kita-ku
Osaka, 530-8552, JPN
Industry Drug Manufacturers - General
Employees 4,315

Competitors & Peers SNPHF

Morningstar does not cover competitors or peers for this firm.

FAQs for Santen Pharmaceutical Co Ltd Stock

Yes. SNPHF has a forward dividend yield of 2.49%. See SNPHF’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

SNPHF’s market cap is 3.60 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

SNPHF’s stock style is Mid Core.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

SNPHF’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare SNPHF’s historical performance against its industry peers and the overall market.